PDCO 45.43 Patterson Companies Inc $PDCO Hit a 52 week high

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
PDCO 45.43 Patterson Companies Inc $PDCO Hit a 52 week high of 45.94 Closing the day 09:45 at 45.43 -0.27 -0.59% With a day low of 45.43 and a total volume of 19,610.

PDCO Recent Posts: http://investorshangout.com/Patterson-Compani...DCO-55071/

PDCO Patterson Companies Inc Recent Headline News

Tracking The Parnassus Core Equity Fund
IVI Guy - at Seeking Alpha - Wed Nov 12, 6:45AM CST

WDFC: 76.57 (-0.76), SJR: 26.59 (+0.18), PRGO: 153.82 (-1.71), XYL: 37.46 (+0.01), CHRW: 73.06 (-0.05), MDLZ: 38.28 (+0.05), MKC: 72.60 (-0.66), MDU: 24.96 (-0.04), SYY: 38.59 (-0.15), PDCO: 45.04 (-0.66), PNR: 68.33 (-0.14), TRI: 38.29 (+0.21), UPS: 106.54 (-1.25), PEP: 97.66 (-0.88), AGN: 197.91 (+1.70), MSI: 65.04 (+0.61), NOV: 71.19 (-0.33), NWN: 46.31 (-0.41), EGN: 67.73 (+0.77), EBAY: 54.31 (-0.06), QCOM: 70.88 (+0.23), AMAT: 22.90 (+0.28), ACN: 84.43 (-0.01), AAPL: 113.74 (+0.92), MA: 83.97 (-0.23), SCHW: 28.90 (+0.11), STR: 23.40 (-0.36), SE: 37.87 (+0.01), GAS: 51.24 (-0.41), IRM: 37.85 (-0.52), WM: 49.04 (-0.33), CMP: 88.27 (-0.10), VRSK: 62.97 (-0.19), GILD: 101.70 (-2.50), EXPD: 43.82 (-0.08), TFX: 115.00 (+0.36), CVS: 89.13 (-1.00), PG: 88.07 (-0.53), PX: 125.69 (-1.04), NVS: 93.89 (-0.49)

Patterson reports November 20
Seeking Alpha - at Seeking Alpha - Thu Nov 06, 2:49PM CST

PDCO: 45.04 (-0.66)

Patterson Companies Second-Quarter Fiscal 2015 Conference Call
Business Wire - Thu Nov 06, 2:16PM CST
Patterson Companies, Inc. (Nasdaq: PDCO), today announced that it will hold its fiscal 2015 second-quarter conference call on Thursday, November 20 at 9 a.m. CT (10 a.m. ET). The company's earnings release will be issued that morning before the market opens.
PDCO: 45.04 (-0.66)

Tracking Yacktman Asset Management Portfolio - Q3 2014 Update
John Vincent - at Seeking Alpha - Wed Nov 05, 5:56AM CST

BDX: 129.15 (-0.16), CHRW: 73.06 (-0.05), CLX: 100.17 (-1.74), SYY: 38.59 (-0.15), XOM: 94.85 (+0.19), WMT: 82.61 (-0.33), PDCO: 45.04 (-0.66), PEP: 97.66 (-0.88), JNJ: 108.16 (-0.91), FOX: 33.61 (+0.06), EBAY: 54.31 (-0.06), FOXA: 35.00 (+0.01), MSFT: 49.49 (-0.12), NWS: 14.94 (+0.13), BK: 39.76 (+0.17), CSCO: 26.20 (+0.52), SYK: 87.70 (-1.14), KO: 42.52 (-0.27), AVP: 10.10 (-0.16), BCR: 163.56 (-2.03), STT: 76.03 (-0.45), COP: 71.16 (+0.81), WFC: 53.33 (-0.06), WLP: 125.33 (-1.30), ORCL: 40.70 (-0.02), USB: 43.73 (-0.20), SIAL: 135.51 (-0.02), MRK: 59.01 (-0.53), PG: 88.07 (-0.53), VIAB: 72.69 (+1.49), CMCSA: 53.87 (-0.43)

Patterson Companies, Quality Systems Ink Dental Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 22, 4:38PM CDT
Through this partnership, Quality Systems Inc. (QSII) intends to leverage Patterson Companies, Inc.'s (PDCO) special market division sales force to set up a new line of business with its dental group practice customers.
ABAX: 54.76 (-0.25), PDCO: 45.04 (-0.66), QSII: 14.92 (-0.07), COO: 160.98 (-0.75)

QSIDental and Patterson Dental Forge Strategic Partnership
Business Wire - Tue Oct 21, 4:00AM CDT
Quality Systems, Inc. (NASDAQ: QSII) announced today that its dental division has entered into an agreement with Patterson Dental Supply, Inc., a leading distributor of dental products, equipment and technology in the U.S. and Canada, and the largest business in the progressive, global Patterson Companies (NASDAQ: PDCO) family of businesses.
PDCO: 45.04 (-0.66), QSII: 14.92 (-0.07)

3 Stocks With Upcoming Ex-Dividend Dates: ACP, PDCO, DRI
at The Street - Tue Oct 07, 9:39AM CDT
ACP PDCO DRI are going ex-dividend tomorrow, Wednesday, October 08, 2014
PDCO: 45.04 (-0.66), DRI: 55.96 (-0.34), ACP: 16.14 (-0.04)

Patterson Companies Announces Strategic Partnership with Abaxis
Business Wire - Wed Oct 01, 7:30AM CDT
Patterson Companies, Inc. (Nasdaq DCO), at its annual investor day, this morning announced a new strategic partnership with Abaxis, Inc. (NasdaqGS: ABAX), a medical products company that manufactures point-of-care blood instrumentation and consumables to the medical, research and veterinary markets. Under the terms of the agreement, Patterson will sell the full line of Abaxis veterinary diagnostic products, including external reference lab services (Abaxis Veterinary Reference Laboratories) and in-clinic testing.
ABAX: 54.76 (-0.25), PDCO: 45.04 (-0.66)

Look for Shares of Patterson to Potentially Pullback after Yesterday's 1.95% Rise
Comtex SmarTrend(R) - Wed Sep 24, 5:27PM CDT
Patterson (NASDAQ DCO) traded in a range yesterday that spanned from a low of $41.23 to a high of $42.26. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $41.62 on volume of 1.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PDCO: 45.04 (-0.66)

Watch for Patterson to Potentially Pullback After Gaining 1.95% Yesterday
Comtex SmarTrend(R) - Wed Sep 24, 5:27PM CDT
Patterson (NASDAQ DCO) traded in a range yesterday that spanned from a low of $41.23 to a high of $42.26. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $41.62 on volume of 1.0 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PDCO: 45.04 (-0.66)

Patterson Companies Announces 2014 Analyst and Investor Day
Business Wire - Wed Sep 24, 1:55PM CDT
Patterson Companies (Nasdaq: PDCO) today announced that it will host its 2014 Analyst and Investor Day on Wednesday, October 1, from 7:30 a.m. to 12 p.m. ET. The conference will feature remarks by Chairman and CEO Scott P. Anderson and Patterson's executive management team.
PDCO: 45.04 (-0.66)

How Will Patterson Cos. (PDCO) Stock be Affected Today By This Analyst Action?
at The Street - Tue Sep 23, 10:38AM CDT
Shares of Patterson Cos. (PDCO) are up after Bank of America/Merrill Lynch placed the company on the US 1 list.
PDCO: 45.04 (-0.66)

Patterson Companies Declares Quarterly Dividend
Business Wire - Tue Sep 09, 12:00PM CDT
The Board of Directors of Patterson Companies, Inc. (Nasdaq DCO), today declared a quarterly cash dividend of $0.20 per share. The dividend will be payable on October 24, 2014, to shareholders of record on October 10, 2014.
PDCO: 45.04 (-0.66)

Is It Time to Buy Danaher Corporation's Stock?
Lee Samaha, The Motley Fool - Motley Fool - Thu Sep 04, 5:30PM CDT
Diversified industrial conglomerate Danaher Corporation remains one of the highest quality stocks in the industrial sector, but there are question marks about its prospects going forward. What should investors do with a stock that has rewarded...
A: 41.40 (-0.05), PDCO: 45.04 (-0.66), DHR: 82.24 (-0.16)

Patterson Companies Announces Upcoming Investor Conference Schedule
Business Wire - Tue Sep 02, 3:36PM CDT
Patterson Companies (Nasdaq DCO) today announced that the company will be presenting at the following conferences in September and October:
PDCO: 45.04 (-0.66)

5 Toxic Stocks You Need to Sell Now
at The Street - Fri Aug 29, 11:30AM CDT
It's time to unload these stocks from your portfolio.
FLIR: 32.39 (-0.05), PDCO: 45.04 (-0.66), EDU: 22.28 (+0.19), LULU: 44.94 (-0.25), RGC: 22.29 (-0.40)

Company News for August 22, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Fri Aug 22, 9:10AM CDT
Companies in the News are: DLTR,PDCO,TTC,CYBX
TTC: 62.25 (-0.48), DLTR: 62.03 (+0.04), PDCO: 45.04 (-0.66), CYBX: 52.36 (+1.05)

Patterson Companies Q1 Fiscal Earnings Rise but Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Aug 21, 9:58AM CDT
Patterson Companies (PDCO) reiterated its earnings per share guidance in the range of $2.20-$2.30 for fiscal 2015.
MCK: 204.54 (-0.28), PDCO: 45.04 (-0.66), IDXX: 149.95 (-2.55), COO: 160.98 (-0.75)

Patterson Companies Reports Fiscal 2015 First Quarter Operating Results
Business Wire - Thu Aug 21, 6:00AM CDT
--National Veterinary Services Limited (NVS) acquisition contributed $174 million to consolidated sales and $0.02 per diluted share to net earnings;
PDCO: 45.04 (-0.66)

5 Stocks Set to Soar on Bullish Earnings
at The Street - Mon Aug 18, 11:30AM CDT
These heavily shorted stocks could get squeezed much higher if they report positive earnings this week.
HAIN: 107.64 (-0.02), GLOG: 19.32 (-0.38), MDT: 69.12 (-0.26), PDCO: 45.04 (-0.66), YOKU: 22.14 (+0.89)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 170

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 108

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 358

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 336

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 364

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 153

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 86

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 372

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Cultural Tech Fusion: The Asia-Pacific Way Forward

Updated Category News Views 64

A High-Tech Twist on Traditional Culture You ever walk into a room and see a robot perform kung fu? I'll admit, it caught me off guard at first. But that's exactly what happened at the "Enduring Heritage, Harmonious Asia-Pacific" special exhibition in Shenzhen. With all the usual high-ranking execs and cultural bigwigs there, nobody expected a showcase where Wing Chun...

Continue Reading

Top 5 Most Recently Viewed Articles

Analyzing Trump's Executive Orders and Their Economic Impact

Updated Category News Views 806

Executive Orders: A Shift in Economic Paradigms President Trump has taken significant steps by issuing a number of executive orders that have raised eyebrows among economists and market analysts alike. According to market expert Louis Navellier, this approach can be characterized as 'shock and awe'. It reflects a bold strategy that could reshape various aspects of the...

Continue Reading
B2PRIME Expands Institutional Reach with Stuart Brock's Addition

Updated Category News Views 173

B2PRIME Welcomes Stuart Brock as Institutional Business Development Manager B2PRIME Group, a leading financial services provider for institutional and professional clients, recently announced the appointment of Stuart Brock as its Institutional Business Development Manager. With over 15 years of experience in electronic trading and institutional sales, Stuart is poised to...

Continue Reading
United Parks & Resorts Inc. Shares Q1 2025 Financial Insights

Updated Category News Views 374

Financial Overview of United Parks & Resorts Inc. United Parks & Resorts Inc. (NYSE: PRKS), a prominent player in the theme park and entertainment sector, has recently shared its financial results for the first quarter of 2025. This report delves into the key metrics and operational insights that define the company’s performance in this period. Attendance and Revenue...

Continue Reading
Seongnam Pavilion Sets New Benchmark at CES 2025 with 41 Companies

Updated Category News Views 178

Seongnam Pavilion Makes Waves at CES 2025 At the latest CES 2025, Seongnam City showcased an impressive turnout at the world's leading consumer electronics exhibition. This year, Seongnam participated with a remarkable delegation of 41 companies, marking the largest participation ever. Focused on enhancing their global footprint, these small and medium-sized enterprises...

Continue Reading
Gaucho Holdings Seizes Opportunities Amid Argentina's Economic Revival

Updated Category News Views 179

Gaucho Holdings and the New Economic Landscape in Argentina Recently, Argentina has entered a new chapter of economic transformation. A shift in leadership, with Javier Milei becoming president, has sparked hopes for fiscal discipline, growth, and development. As the country embraces pro-market reforms, Gaucho Group Holdings, Inc. (NASDAQ: VINO) positions itself to...

Continue Reading